review on glp-1 agonists and psychiatric effects of GLP‐1 receptor agonists: A systematic of emerging evidence Prospects of GLP-1 Therapies for

Treatment discontinuation among users of GLP-1 receptor agonists and SGLT2 inhibitors in a national population of individuals with type 2 diabetes

Topiramate is not a controlled substance, but it carries its own regulatory requirements, including the REMS (Risk Evaluation and Mitigation Strategy) program that Qsymia must follow due to the risk of birth defects

doi: 10.1038/oby.2009.184 122 BelloNTKemmMHOfeldtEMMoranTH

For pancreatitis, there was a 0.5% incidence of pancreatitis in people taking Ozempic, a 0.8% risk in people taking Saxenda, and a 0.01% incidence in people taking Contrave, representing a more than ninefold increase

Funding PE was funded by the Medical Research Council and now by Higher Education Funding Council for England (HEFCE)